$3.73
2.61% yesterday
Nasdaq, Sep 27, 10:00 pm CET
ISIN
CH1125843347
Symbol
SOPH

SOPHiA Genetics SA Stock price

$3.73
+0.12 3.32% 1M
-1.53 29.09% 6M
-0.98 20.81% YTD
+1.31 54.13% 1Y
-13.03 77.74% 3Y
-13.03 77.74% 5Y
-13.03 77.74% 10Y
Nasdaq, Closing price Fri, Sep 27 2024
-0.10 2.61%
ISIN
CH1125843347
Symbol
SOPH

Key metrics

Market capitalization $250.39m
Enterprise Value $175.06m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.70
P/S ratio (TTM) P/S ratio 3.86
P/B ratio (TTM) P/B ratio 2.09
Revenue growth (TTM) Revenue growth 20.14%
Revenue (TTM) Revenue $64.94m
EBIT (operating result TTM) EBIT $-70.17m
Free Cash Flow (TTM) Free Cash Flow $-47.53m
Cash position $105.40m
EPS (TTM) EPS $-1.02
P/E forward negative
P/S forward 3.80
EV/Sales forward 2.66
Short interest 0.08%
Show more

Is SOPHiA Genetics SA a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

SOPHiA Genetics SA Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a SOPHiA Genetics SA forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a SOPHiA Genetics SA forecast:

Buy
80%
Hold
20%

Financial data from SOPHiA Genetics SA

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
65 65
20% 20%
100%
- Direct Costs 21 21
18% 18%
32%
44 44
21% 21%
68%
- Selling and Administrative Expenses 70 70
3% 3%
108%
- Research and Development Expense 36 36
3% 3%
56%
-62 -62
13% 13%
-95%
- Depreciation and Amortization 8.28 8.28
16% 16%
13%
EBIT (Operating Income) EBIT -70 -70
10% 10%
-108%
Net Profit -67 -67
15% 15%
-103%

In millions USD.

Don't miss a Thing! We will send you all news about SOPHiA Genetics SA directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

SOPHiA Genetics SA Stock News

Neutral
PRNewsWire
13 days ago
Research highlights the use of multimodal machine learning to identify non-small cell lung cancer patients predicted to derive the most benefit from combination immunotherapy BOSTON and ROLLE, Switzerland , Sept. 14, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, will unveil new research at the European Soc...
Neutral
PRNewsWire
16 days ago
Research presented will include the applications of new diagnostic tools and machine learning multimodal signatures in clinical trials BOSTON and ROLLE, Switzerland , Sept. 12, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, will be presenting multiple posters at the European Society for Medical Oncol...
Neutral
PRNewsWire
16 days ago
The global collective intelligence network aims to accelerate precision oncology research and care BOSTON and ROLLE, Switzerland , Sept. 12, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an update that several world-renowned healthcare organizations have joined SOPHiA UNITY.
More SOPHiA Genetics SA News

Company Profile

SOPHiA GENETICS SA is a healthcare technology company, which establishes the practice of data driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.

Head office Switzerland
CEO Jurgi Camblong
Employees 449
Founded 2011
Website www.sophiagenetics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today